Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-27 | New | $49,999,533 | $49,999,533 | Equity Only | 06b | SEC link |
| 2023-11-27 | New | $7,722,217 | $7,722,217 | Equity Only | 06b | SEC link |
| 2023-11-27 | New | $31,887,138 | $31,887,138 | Equity Only | 06b | SEC link |
| 2023-11-27 | New | $59,261,815 | $59,261,815 | Equity Only | 06b | SEC link |
| 2023-11-27 | New | $45,000,223 | $45,000,223 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Po Yu (Jeff) Chen | Director |
| Christopher Nixon Cox | Director |
| Chris Dimitropoulos | Director |
| Andrew Dreyfus | Director |
| Amit Etkin | Director, Executive |
| Michael Hanley | Executive |
| Michael Liang | Director |
| Husseini Manji | Director |
| Raymond Sanchez | Director |
| Adam Savitz | Executive |
| Nicholas C. Smith | Executive |
| Aaron Weaver | Director |
| Gwill York | Director |